October 5, 2012 – Change of date!
2 PM in Mainz, Germany
TRON – Building 708 at University Medical Center Mainz
Prof. Dr. Ton Schumacher
The Netherlands Cancer Institute, Amsterdam
“Dissecting cytotoxic T cell immunity in mice and men”
Prof. Schuhmacher’s team at the Netherlands Cancer Institute investigates and designs technologies to examine and modify antigen-specific T cell immunity and then use these novel tools to unravel and manipulate the molecular processes underlying immune recognition by T lymphocytes. Within these projects, a main focus is on the design and testing of novel concepts for adoptive immunotherapy.
Ton Schumacher performed his Ph.D. research from 1988-1992 at The Netherlands Cancer Institute where he studied the interactions of MHC class I molecules with antigenic peptides in the laboratory of Hidde Ploegh. After a brief stint as a post-doc in the laboratory of Hidde Ploegh at the Massachusetts Institute of Technology, he joined the group of Peter Kim at the Whitehead Institute in Cambridge, USA in 1994. During this post-doctoral training he developed a novel screening technology for biological libraries. He joined the Netherlands Cancer Institute as an Assistant Member in 1996 to study the development of T cell immunity through biotechnological approaches. Ton Schumacher is currently Full Member of the Netherlands Cancer Institute and is recipient of a Pioneer Award.